Press Releases

ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement
Press Release
ERS Genomics and Université de Montréal sign CRISPR/Cas9 license agreement
Posted on
ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement
Press Release
ERS Genomics and Medicines Discovery Catapult sign CRISPR/Cas9 license agreement
Posted on
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
Press Release
ERS Genomics and IRBM sign CRISPR/Cas9 license agreement
Posted on
ERS Genomics appoints John E Milad as Chief Executive Officer
Press Release
ERS Genomics appoints John E Milad as Chief Executive Officer
Posted on
Update: Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration
Press Release
Update: Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration
Posted on
Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement
Press Release
Ricoh and ERS Genomics enter into CRISPR/Cas9 license agreement
Posted on
ERS Genomics and StemSight sign CRISPR/Cas9 license agreement
Press Release
ERS Genomics and StemSight sign CRISPR/Cas9 license agreement
Posted on
Key Charpentier/Doudna CRISPR patent upheld by Japanese Patent Office
Press Release
Key Charpentier/Doudna CRISPR patent upheld by Japanese Patent Office
Posted on
New CRISPR/Cas9 Licensing Agreement for ERS Genomics & CHUM Research Centre, Montreal
Press Release
New CRISPR/Cas9 Licensing Agreement for ERS Genomics & CHUM Research Centre, Montreal
Posted on
ERS Genomics Limited (‘ERS’) completes licensing agreement with Syngene International
Press Release
ERS Genomics Limited (‘ERS’) completes licensing agreement with Syngene International
Posted on
ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement
Press Release
ERS Genomics & Demeetra Enter Into CRISPR/Cas9 Licensing Agreement
Posted on
ERS Genomics & AlgenScribe Enter Into CRISPR/Cas9 Licensing Agreement
Press Release
ERS Genomics & AlgenScribe Enter Into CRISPR/Cas9 Licensing Agreement
Posted on
ERS Genomics & Santa Cruz Biotechnology Enter Into CRISPR/Cas9 Licensing Agreement
Press Release
ERS Genomics & Santa Cruz Biotechnology Enter Into CRISPR/Cas9 Licensing Agreement
Posted on
Reflections on BIO International
Press Release
Reflections on BIO International
Posted on
ERS Genomics & Transomic Technologies enter into CRISPR/Cas9 Licensing Agreement
Press Release
ERS Genomics & Transomic Technologies enter into CRISPR/Cas9 Licensing Agreement
Posted on
Manipulating the Fabric of Life
Press Release
Manipulating the Fabric of Life
Posted on
SynBioBeta 2023
Press Release
SynBioBeta 2023
Posted on
ERS Genomics & abm enter into CRISPR/Cas9 Licensing Agreement
Press Release
ERS Genomics & abm enter into CRISPR/Cas9 Licensing Agreement
Posted on
LSPN Boston 2023: Life Science IP Review
Press Release
LSPN Boston 2023: Life Science IP Review
Posted on
BIO Europe, Basel 2023: Our thoughts
Press Release
BIO Europe, Basel 2023: Our thoughts
Posted on